| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2000 | DE19834007C1 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung Estradiolhaltiges patch for transdermal administration of hormones and its use |
| 02/24/2000 | DE19834006A1 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen Estradiolhaltiges patch for transdermal administration of hormones |
| 02/24/2000 | CA2740912A1 Carbohydrate mixtures |
| 02/24/2000 | CA2714085A1 Method of manufacture of 1,3-oxathiolane nucleosides |
| 02/24/2000 | CA2599597A1 .beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 02/24/2000 | CA2553126A1 Oral sustained-release preparation of fasudil hydrochloride |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340745A1 Azepinyland linear compounds and their use for vision and memory disorders |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340700A1 Photocyclized rapamycins |
| 02/24/2000 | CA2340668A1 Heterocyclic thioesters or ketones for vision and memory disorders |
| 02/24/2000 | CA2340419A1 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 02/24/2000 | CA2340350A1 Phenyl yanthine derivatives |
| 02/24/2000 | CA2340341A1 Calcilytic compounds |
| 02/24/2000 | CA2340322A1 Dnazymes and methods for treating restenosis |
| 02/24/2000 | CA2340259A1 Treatment of fecal incontinence |
| 02/24/2000 | CA2340200A1 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones |
| 02/24/2000 | CA2340176A1 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | CA2340168A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 02/24/2000 | CA2340167A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | CA2340165A1 Enhancer of cell differentiation induction factor |
| 02/24/2000 | CA2340117A1 Treatment of vasodilatory headache |
| 02/24/2000 | CA2340092A1 Substituted isoquinoline derivatives and their use as anticonvulsivants |
| 02/24/2000 | CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | CA2340068A1 Calcilytic compounds |
| 02/24/2000 | CA2340053A1 C3a receptor ligands |
| 02/24/2000 | CA2339986A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 02/24/2000 | CA2339970A1 Nematicidal pyrazoles |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339634A1 Amine derivatives |
| 02/24/2000 | CA2339562A1 1h-imidazopyridine derivatives |
| 02/24/2000 | CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | CA2339337A1 Drug targets in candida albicans |
| 02/24/2000 | CA2339300A1 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | CA2338967A1 Improved omeprazole process and compositions thereof |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/24/2000 | CA2336154A1 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 02/24/2000 | CA2336152A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders |
| 02/24/2000 | CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336147A1 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | CA2336088A1 Heterocyclic esters or amides for vision and memory disorders |
| 02/24/2000 | CA2336080A1 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336060A1 Small molecule carbamates or ureas for vision and memory disorders |
| 02/24/2000 | CA2335815A1 Compositions and uses for vision and memory disorders |
| 02/24/2000 | CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | CA2335810A1 Use of sulfonamides for treating vision and memory disorders |
| 02/24/2000 | CA2306567A1 Plasminogen activator inhibitor-1 production inhibitor |
| 02/24/2000 | CA2305768A1 Compositions and methods for treating lysosomal storage disease |
| 02/24/2000 | CA2280633A1 Aspartic protease inhibitors |
| 02/24/2000 | CA2277242A1 Process for pyrrolidinyl hydroxamic acid compounds |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/23/2000 | EP0980864A2 Sulphonamide derivatives |
| 02/23/2000 | EP0980684A2 Use of active substance combinations comprising flavonoids and uv filters as antiviral active principle |
| 02/23/2000 | EP0980441A1 Methods for measuring cellular proliferation and destruction rates in vitro and in vivo |
| 02/23/2000 | EP0980437A1 HMG-CoA REDUCTASE INHIBITOR PREPARATION PROCESS |
| 02/23/2000 | EP0980433A1 Uncoupling protein homologue: ucp 3 |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980424A2 Enzymatic nucleic acids: synthesis, selection and use |
| 02/23/2000 | EP0980386A2 Estrogen receptor crystals and ligands |
| 02/23/2000 | EP0980384A1 Pregnane 3,2o diol mono- and di-sulphates |
| 02/23/2000 | EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 02/23/2000 | EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 02/23/2000 | EP0980381A1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders |
| 02/23/2000 | EP0980379A2 Chimeric oligonucleotides and the use thereof |
| 02/23/2000 | EP0980377A1 Anti-viral pyrimidine nucleoside analogues |
| 02/23/2000 | EP0980374A1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/23/2000 | EP0980373A1 Reverse-turn mimetics and methods relating thereto |
| 02/23/2000 | EP0980372A2 CYTOTOXIC COMPOUNDS: DERIVATIVES OF THE PYRIDO 2,3,4-$i(kl)] ACRIDINE RING SYSTEM |
| 02/23/2000 | EP0980371A1 Tricyclic pyridone analogues as gaba-a receptor ligands |
| 02/23/2000 | EP0980370A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 02/23/2000 | EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 02/23/2000 | EP0980368A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 02/23/2000 | EP0980367A1 Antithrombotic agents |
| 02/23/2000 | EP0980366A1 Antithrombotic agents |
| 02/23/2000 | EP0980365A1 Alpha-tocopherol 4-aminobenzoic acid ester compounds and method for preparing the same |
| 02/23/2000 | EP0980363A1 Preparation of isoflavones from legumes |
| 02/23/2000 | EP0980362A1 Substituted heterocycles and their use in medicaments |
| 02/23/2000 | EP0980359A1 Benzimidazole derivative |
| 02/23/2000 | EP0980358A1 Pharmacological agents |
| 02/23/2000 | EP0980357A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors |
| 02/23/2000 | EP0980354A2 Vitamin d 3? analogs with bis c-20 side chains |
| 02/23/2000 | EP0980351A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/23/2000 | EP0980349A1 Conjugated linolenic acid-based synthetic triglycerides |
| 02/23/2000 | EP0980263A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 02/23/2000 | EP0980259A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 02/23/2000 | EP0980258A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
| 02/23/2000 | EP0980255A2 Adhesion prevention and an endoscopic insufflation system therefor |
| 02/23/2000 | EP0980254A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| 02/23/2000 | EP0980251A1 Tissue factor for influencing blood vessel formation |
| 02/23/2000 | EP0980250A1 Plant extracts for the treatment of increase bone resorption |
| 02/23/2000 | EP0980249A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv |
| 02/23/2000 | EP0980248A1 Improvements in or relating to long-acting antimicrobials |
| 02/23/2000 | EP0980247A1 Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain |
| 02/23/2000 | EP0980246A1 Therapy for constipation |
| 02/23/2000 | EP0980245A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction |
| 02/23/2000 | EP0980244A1 Use of quinazoline compounds for the treatment of polycystic kidney disease |